Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devin Incerti

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|June 10, 2023
Multi-state network meta-analysis of progression and survival dataJeroen P Jansen, Devin Incerti, Thomas A Trikalinos
Pharmacoeconomics|August 9, 2019
Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value ProjectJeroen P Jansen, Devin Incerti, Mark T Linthicum
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care SystemJeroen P Jansen, Devin Incerti, Jeffrey R Curtis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology AssessmentDevin Incerti, Howard Thom, Gianluca Baio, et al.
Pharmaceutical Statistics|October 4, 2022
A meta-analytic framework to adjust for bias in external control studiesDevin Incerti, Michael T Bretscher, Ray Lin, et al.
Pharmacoeconomics - Open|February 22, 2018
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm InfantsAhva Shahabi, Desi Peneva, Devin Incerti, et al.
Pharmaceutical Statistics|July 17, 2022
Left truncation in linked data: A practical guide to understanding left truncation and applying it using SAS and RYanling Jin, Thanh G N Ton, Devin Incerti, et al.
Health Economics|February 22, 2020
An empirical investigation of time-varying cost-effectiveness across the product life cycleWarren Stevens, Devin Incerti, Desi Peneva, et al.
Statistics in Medicine|July 24, 2021
Penalized regression for left-truncated and right-censored survival dataSarah F McGough, Devin Incerti, Svetlana Lyalina, et al.
Pharmacoeconomics|February 10, 2019
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid ArthritisDevin Incerti, Jeffrey R Curtis, Jason Shafrin, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|June 10, 2023
Multi-state network meta-analysis of progression and survival dataJeroen P Jansen, Devin Incerti, Thomas A Trikalinos
Pharmacoeconomics|August 9, 2019
Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value ProjectJeroen P Jansen, Devin Incerti, Mark T Linthicum
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care SystemJeroen P Jansen, Devin Incerti, Jeffrey R Curtis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology AssessmentDevin Incerti, Howard Thom, Gianluca Baio, et al.
Pharmaceutical Statistics|October 4, 2022
A meta-analytic framework to adjust for bias in external control studiesDevin Incerti, Michael T Bretscher, Ray Lin, et al.
Pharmacoeconomics - Open|February 22, 2018
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm InfantsAhva Shahabi, Desi Peneva, Devin Incerti, et al.
Pharmaceutical Statistics|July 17, 2022
Left truncation in linked data: A practical guide to understanding left truncation and applying it using SAS and RYanling Jin, Thanh G N Ton, Devin Incerti, et al.
Health Economics|February 22, 2020
An empirical investigation of time-varying cost-effectiveness across the product life cycleWarren Stevens, Devin Incerti, Desi Peneva, et al.
Statistics in Medicine|July 24, 2021
Penalized regression for left-truncated and right-censored survival dataSarah F McGough, Devin Incerti, Svetlana Lyalina, et al.
Pharmacoeconomics|February 10, 2019
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid ArthritisDevin Incerti, Jeffrey R Curtis, Jason Shafrin, et al.
Pageof 3